* Newstin.co.uk is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.co.uk and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.co.uk is for sale! *
Full Coverage

FTC says pharmaceutical companies keep cheap drugs off market through legal settlements

pharmiweb.co.uk
21-May-2008
        
Story Timeline:  145 days

WASHINGTON (AP) - Pharmaceutical companies are using legal settlements with generic drugmakers to delay the introduction of cheaper medicines, a government agency said Wednesday. In a 12-month period that ended last Sept. 30, 14 of 33 agreements to settle patent litigation between brand-name drug... [read full story]                    

Add Comment
Latest article on this story:

FTC's Bureau of Competition Issues Statement and Report Regarding 2007 Pharmaceutical Settlement...

 crowell.com 23-May-2008
First article on this story:

Legal settlements delay cheaper drugs

 thehour.com 20-May-2008
Selected publications with coverage of this story:
orglex.com reuters.com iht.com law.com ftc.gov usatoday.com thehour.com pitt.edu pharmiweb.co.uk wsj.com canadianbusiness.com crowell.com
RELATED
Found 4 documents:

Drug Firms Inflating Prices of Generic Drugs - KDI

chosun.com
22-May-2008
        

A 20-mg tablet of a drug used to treat hyperlipidaemia made by a U.S.-based multinational pharmaceutical company sells for W1,219 in Korea (US$1=W1,044). As many as 87 different generic versions of this drug are available, containing the same active ingredients as the original. Forty such...

                   

Pharmaceutical Pay-to-Delay Deals Hurt Consumers Says FTC

pharmiweb.co.uk
22-May-2008
        

Legal deals between brand-name drug manufacturers and generics firms, called "Pay-to-Delay", are costing consumers, says an annual report released by the US Federal Trade Commission (FTC). Fourteen settlements of this kind were made between pharmaceutical companies in 2007, usually following a...

                   

FTC's Bureau of Competition Issues FY 2007 Summary of Pharmaceutical Company Settlement Agreements

pharmiweb.co.uk
22-May-2008
        

Nearly Half Involved Payment to Generic Firms, Restricted Generics’ Ability to Enter the Market WASHINGTON, May 21, 2008-The Federal Trade Commission’s Bureau of Competition today issued a summary of agreements filed with the agency in fiscal year 2007 (ending September 30, 2007) by generic and...

FTC says pharmaceutical companies keep cheap drugs off market through legal settlements

canadianbusiness.com
21-May-2008
        

WASHINGTON (AP) - Pharmaceutical companies are using legal settlements with generic drugmakers to delay the introduction of cheaper medicines, a government agency said Wednesday. In a 12-month period that ended last Sept. 30, 14 of 33 agreements to settle patent litigation between brand-name drug...

Related categories